Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer. | Int J Mol Sci | 2021 | 34207360 | PubTator, text mining | PubMed |
| Nanotechnology of Tyrosine Kinase Inhibitors in Cancer Therapy: A Perspective. | Int J Mol Sci | 2021 | 34207175 | PubTator, text mining | PubMed |
| Circular RNAs: Emerging Regulators of the Major Signaling Pathways Involved in Cancer Progression. | Cancers (Basel) | 2021 | 34205978 | PubTator, text mining | PubMed |
| Epithelial-Mesenchymal Transition (EMT): The Type-2 EMT in Wound Healing, Tissue Regeneration and Organ Fibrosis. | Cells | 2021 | 34201858 | PubTator, text mining | PubMed |
| Comparison of Resistance Spectra after First and Second Line Osimertinib Treatment Detected by Liquid Biopsy. | Cancers (Basel) | 2021 | 34201252 | PubTator, text mining | PubMed |
| Molecular Characterization of Muellerian Tumors of the Urinary Tract. | Genes (Basel) | 2021 | 34200508 | PubTator, text mining | PubMed |
| Molecular Pathogenesis and Regulation of the miR-29-3p-Family: Involvement of ITGA6 and ITGB1 in Intra-Hepatic Cholangiocarcinoma. | Cancers (Basel) | 2021 | 34199886 | PubTator, text mining | PubMed |
| Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation. | Cancers (Basel) | 2021 | 34198671 | PubTator, text mining | PubMed |
| Engineering strategies to capture the biological and biophysical tumor microenvironment in vitro. | Adv Drug Deliv Rev | 2021 | 34197895 | PubTator, text mining | PubMed |
| Aligned forces: Origins and mechanisms of cancer dissemination guided by extracellular matrix architecture. | Curr Opin Cell Biol | 2021 | 34186415 | PubTator, text mining | PubMed |
| Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation. | Environ Int | 2021 | 34186270 | PubTator, text mining | PubMed |
| Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib. | J Exp Clin Cancer Res | 2021 | 34174931 | PubTator, text mining | PubMed |
| Bioactivity descriptors for uncharacterized chemical compounds. | Nat Commun | 2021 | 34168145 | PubTator, text mining | PubMed |
| A mutation of EYA1 gene in a Chinese Han family with Branchio-Oto syndrome. | Medicine (Baltimore) | 2021 | 34160378 | PubTator, text mining | PubMed |
| A protocol for transdifferentiation of human cardiac fibroblasts into endothelial cells via activation of innate immunity. | STAR Protoc | 2021 | 34151292 | PubTator, text mining | PubMed |
| Inhibition of discoidin domain receptors by imatinib prevented pancreatic fibrosis demonstrated in experimental chronic pancreatitis model. | Sci Rep | 2021 | 34145346 | PubTator, text mining | PubMed |
| Stress granules inhibit fatty acid oxidation by modulating mitochondrial permeability. | Cell Rep | 2021 | 34133922 | PubTator, text mining | PubMed |
| Immunotherapy in the Treatment of Urothelial Bladder Cancer: Insights From Single-Cell Analysis. | Front Oncol | 2021 | 34123863 | PubTator, text mining | PubMed |
| Carbon Based Nanodots in Early Diagnosis of Cancer. | Front Chem | 2021 | 34109155 | PubTator, text mining | PubMed |
| Collagen Biosynthesis, Processing, and Maturation in Lung Ageing. | Front Med (Lausanne) | 2021 | 34095157 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=46